Online Chats hosted by Leukemia and Lymphoma Society
The Leukemia & Lymphoma Society hosts weekly online chats moderated by an oncology social worker.
Recognizing the needs of cancer patients from the initial phase of diagnosis through treatment decisions and survivorship, the online chats bring non-Hodgkin's lymphoma, chronic myeloid leukemia, myeloma and young adult survivors together to share experiences. The online chats are not a replacement for psychotherapy or support groups.
The live, weekly two-hour online chats provide a friendly forum for registrants. Each chat is moderated by an oncology social worker and is password protected. The role of the moderator/facilitator is to provide support and guide conversation, as needed, throughout the chats. The moderator's role is largely determined by the wants and needs of participants in each chat.
By registering for the chat, participants need to understand and agree to LLS' chat requirements including posting truthful and appropriate comments, staying on topic, listening to and respecting others, and protecting privacy.
Chats available for different conditions
The current list of chat subjects includes:
- Living with NHL: Gaining a Sense of Balance
- Living with CML
- Myeloma
- YAconnect: Young Adults Living with Leukemia, Lymphoma and Myeloma
Click here to get more information or register for the free online live chat.
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
